Metastatic Pancreatic Cancer Second-Line Treatment Options: Is the Difference Only in Cost?

ConclusionAs a result, second-line treatments were compared, and no statistically significant difference was found between them. For this reason, the side effects of previously used drugs and the side effects of new drugs to be used, as well as their costs, should be evaluated when choosing a treatment.
Source: Journal of Gastrointestinal Cancer - Category: Cancer & Oncology Source Type: research